The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 08, 2014
Filed:
May. 26, 2009
Philippe Neven, Nandrin, BE;
Didier Serteyn, Tavier, BE;
Robert Kiss, St Pieters Leeuw, BE;
Veronique Mathieu, Brussels, BE;
Didier Cataldo, Olne, BE;
Natacha Rocks, La Calamine, BE;
Eva Scheer, Dolembreux-Sprimont, BE;
Philippe Neven, Nandrin, BE;
Didier Serteyn, Tavier, BE;
Jacques Delarge, Dolembreux-Sprimont, BE;
Robert Kiss, St Pieters Leeuw, BE;
Veronique Mathieu, Brussels, BE;
Didier Cataldo, Olne, BE;
Natacha Rocks, La Calamine, BE;
Universite Libre de Bruxelles, Brussels, BE;
Universite de Liege, Liege, BE;
Abstract
The present invention relates to the medical field. In a first aspect the present invention relates to novel water soluble cyclodextrin-curcumin complexes having a pharmacological activity, in particular an anti-tumor and/or anti-inflammatory activity, and improved physico-chemical properties. In a second aspect, the present invention relates to a method for preparation of said water soluble curcumin derivatives. The invention further relates in a third aspect to a pharmaceutical composition comprising an effective amount of said water soluble curcumin derivatives. In a fourth aspect, the present invention concerns the use of said water soluble cucumin derivatives as a medicament and the use of said water soluble curcumin derivatives for the preparation of a medicament for the treatment of cancer and inflammatory diseases. In a fifth aspect, the present invention relates to the use of a pharmaceutical composition comprising said water soluble curcumin derivatives in the treatment of cancer and inflammatory diseases and to a new pharmaceutical composition comprising said water soluble curcumin derivatives.